Company Name: American College of Cardiology
About: Make well-informed decisions on antithrombotic therapy for your non-valvular AF
patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a
patient's renal function and risk of ischemic stroke, thromboembolism, and
bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke
prevention
• Generate individualized risk for antithrombotic therapy options
based on individual clinical trials.
The following contact options are available: Pricing Information, Support, General Help, and Press Information/New Coverage (to guage reputation). Discover which options are the fastest to get your customer service issues resolved.
NOTE: If the links below doesn't work for you, Please go directly to the Homepage of American College of Cardiology
E-Mail: [email protected]
Website: 🌍 Visit AnticoagEvaluator Website
Privacy Policy: http://www.acc.org/footer-pages/privacy-policy
Developer: American College of Cardiology Foundation
Protect your data and wallet. We investigate the developer's website (Acc.org), verify they're legit, and uncover hidden scams or complaints.
by SDCardioDoc
Since updating to new risk models… the app doesn’t display and actual CHADs-Vasc Score. I understanding what you are going for, but this honestly makes the app less useful and no longer my go-to. Such a shame. Used it for many years and loved it prior to this change.
by Pkilaru
It's become less functional since the IOS 8; you can no longer choose a therapy and see the details of its usefulness or the lack thereof. However, here is temporary workaround until they fix it: after selecting the risk factors for your patient, you click on the email icon and it will give you the relative risk reductions for all of the therapies.
I know it's inelegant but is still functional.
Hopefully, they will fix it soon.
by Jaa131
Can no longer select and receive details for a particular therapy option. This needs to be fixed.